Date Requested: February 24, 2015
Time Requested: 09:58 AM
Agency: Supreme Court of Appeals
CBD Number: Version: Bill Number: Resolution Number:
3308 Introduced HB2880
CBD Subject: Crime


FUND(S):



Sources of Revenue:

General Fund

Legislation creates:

A New Program



Fiscal Note Summary


Effect this measure will have on costs and revenues of state government.


    Currently, this bill would require the Court to participate in a pilot program in five Adult Drug Court (ADC) programs, wherein persons who have been clinically diagnosed with opioid addiction are selected by the ADC program to receive medically assisted treatment.
    



Fiscal Note Detail


Effect of Proposal Fiscal Year
2015
Increase/Decrease
(use"-")
2016
Increase/Decrease
(use"-")
Fiscal Year
(Upon Full
Implementation)
1. Estmated Total Cost 0 2,880,000 2,880,000
Personal Services 0 0 0
Current Expenses 0 0 0
Repairs and Alterations 0 0 0
Assets 0 0 0
Other 0 0 0
2. Estimated Total Revenues 0 0 0


Explanation of above estimates (including long-range effect):


    This bill has serious fiscal impact on the judiciary‚Äôs budget. Specifically, the Court has never paid for vivitrol. Programs currently using it are doing so through either Medicaid or a federal grant. Medicaid will only pay for up to one year. This could raise an issue, as the average time for successful completion of ADC is 18 months.
    
     Please note that vivitrol costs $800.00 to $1,200.00 per shot, and shots are administered monthly. As this program authorizes up to 200 participants from ADC programs, the upper range of cost (if there is no Medicaid or insurance coverage for the vivitrol), would be $2,880,000.00 per year, or $14,400.00, annually, per participant.
    



Memorandum


    



    Person submitting Fiscal Note: Tina A. Payne
    Email Address: tina.payne@courtswv.gov